Drug use and HIV medication adherence in people living with HIV

References

• Hedegaard H, Miniño AM, Warner M. Drug overdose deaths in the United States, 1999–2017. NCHS Data Brief, no 329. Hyattsville, MD: National Center for Health Statistics, 2018. https://www.cdc.gov/nchs/products/databriefs/db329.htm.
   Google Scholar
• Cunningham CO, Sohler NL, Berg KM, Shapiro S, Heller D. Type of substance use and access to HIV related health care. AIDS Patient Care STDS. 2006;20(6):399–407.
   PubMed Web of Science ®Google Scholar
• Kapadia F, Vlahov D, Donahoe RM, Friedland G. The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clin Infect Dis. 2005;41(7):1027–1034.
   PubMed Web of Science ®Google Scholar
• Khalsa JH, Treisman G, McCance-Katz E, Tedaldi E. Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse. Subst Abus. 2008;29(3):5–16.
   PubMed Web of Science ®Google Scholar
• Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr. 2001;27(3):251–259.
   PubMed Web of Science ®Google Scholar
• Arnsten JH, Demas PA, Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002;17(5):377–381.
   PubMed Web of Science ®Google Scholar
• Hogg RS, Heath K, Bangsberg D, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002;16(7):1051–1058.
   PubMed Web of Science ®Google Scholar
• Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdfSection. Accessed August 10, 2014.
   Google Scholar
• Malta M, Magnanini MMF, Strathdee SA, Bastos FI. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav. 2010;14(4):731–747.
   PubMed Web of Science ®Google Scholar
• Hinkin CH, Barclay TR, Castellon SA, et al. Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav. 2007;11(2):185–194.
   PubMed Web of Science ®Google Scholar
• Gonzalez A, Barinas J, O’Cleirigh C. Substance use: impact on adherence and HIV medical Treatment. Curr Hiv/Aids Rep. 2011;8(4):223–234.
   PubMedGoogle Scholar
• Waldrop-Valverde D, Valverde E. Homelessness and psychological distress as contributors to antiretroviral nonadherence in HIV-positive injecting drug users. AIDS Patient Care STDS. 2005;19(5):326–334.
   PubMed Web of Science ®Google Scholar
• Bauermeister JA. Latino gay men’s drug functionality: the role of social networks and social support. J Ethn Substance Abuse. 2008;1:41–65.
   Google Scholar
• Decorte T. Drug users’ perceptions of ‘controlled’ and ‘uncontrolled’ use. Int J Drug Policy. 2001;12(4):297–320.
   Google Scholar
• Dean AJ, Saunders JB, Bell J. Heroin use, dependence and attitudes to treatment in non-treatment-seeking heroin users: a pilot study. Subst Use Misuse. 2011;46(4):417–425.
   PubMed Web of Science ®Google Scholar
• Laudet A, Hill T. Life experiences in active addiction and in recovery among treated and untreated persons: a national study. J Addict Dis. 2015;34(1):18–35.
   PubMed Web of Science ®Google Scholar
• Dobkin PL, De Civita M, Paraherakis A, Gill K. The role of functional social support in treatment retention and outcomes among outpatient adult substance abusers. Addiction. 2002;97(3):347–356.
   PubMed Web of Science ®Google Scholar
• Ritter A, Cameron J. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Drug Alcohol Rev. 2006;25(6):611–624.
   PubMed Web of Science ®Google Scholar
• Stancliff S, Phillips BW, Maghsoudi N, Joseph H. Harm reduction: front line public health. J Addict Dis. 2015;34(2–3):206–219.
   PubMed Web of Science ®Google Scholar
• Hyshka E, Strathdee S, Wood E, Kerr T. Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research. Int J Drug Policy. 2012;23(4):261–270.
   PubMed Web of Science ®Google Scholar
• Fanucchi L, Springer SA, Korthuis PT. Medications for treatment of opioid use disorder among persons living with HIV. Curr HIV/AIDS Rep. 2019;16(1):1–6.
   PubMed Web of Science ®Google Scholar
• Kennedy MC, Karamouzian M, Kerr T. Public health and public order outcomes associated with supervised drug consumption facilities: a systemic review. Curr HIV/AIDS Rep. 2017;14(5):161–183.
   PubMed Web of Science ®Google Scholar
• Richard L, Potvin L, Kishchuk N, Prlic H, Green LW. Assessment of the integration of the ecological approach in health promotions programs. Am J Health Promot. 1996;10(4):318–327.
   PubMed Web of Science ®Google Scholar
• Cunningham C. Project FIRST – financial incentives to reduce substance use and improve treatment. ClinicalTrials.gov, 2011 https://clinicaltrials.gov/ct2/show/NCT01376570.
   Google Scholar
• Glenn MC, Sohler NL, Starrels JL, et al. Characteristics of methadone maintenance treatment patients prescribed opioid analgesics. Subst Abus. 2016;37(3):387–391.
   PubMed Web of Science ®Google Scholar
• Gale NL, Heath G, Cameron E, Rashid S, Redwood S. Using the framework methods for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13(1):117.
   PubMed Web of Science ®Google Scholar
• Dedoose Version 8.0.35, Web Application for Managing, Analyzing, and Presenting qualitative and Mixed Method Research Data. Los Angeles, CA: SocioCultural Research Consultants, LLC; 2018. www.dedoose.com.
   Google Scholar
• Burr CK, Storm DS, Hoyt MJ, et al. Integrating health and prevention services in syringe access programs: A strategy to address unmet needs in a high-risk population. Public Health Rep. 2014;129(1_suppl 1):26–32.
   PubMedGoogle Scholar
• Jeynes KD, Gibson EL. The importance of nutrition in aiding recovery for substance abuse disorders: A review. Drug Alcohol Depen. 2017;179(1):229–239.
   PubMedGoogle Scholar
• Brown S, Tracy EM, Jun M, Park H, Min MO. Personal network recovery enablers and relapse risks for women with substance dependence. Qual Health Res. 2015;25(3):371–385.
   PubMed Web of Science ®Google Scholar
• Kelly PJ, Ramaswamy M, Li X, Litwin AH, Berg KM, Arnsten JH. Social networks of substances users with HIV infection: application of the Norbeck Social Support Scale. West J Nurs Res. 2012;34(5):621–634.
   PubMed Web of Science ®Google Scholar
• Knowlton A, Hua W, Latkin C. Social support networks and medical service use among HIV-positive injection drug users: implications to intervention. AIDS Care. 2005;17(4):479–492.
   PubMed Web of Science ®Google Scholar
• Tucker JA, Cheong J, Chandler SD, Crawford SM, Simpson CA. Simpson CA Social networks and substance use among at-risk emerging adults living in disadvantaged urban areas in the southern United States: a cross-sectional naturalistic study. Addiction. 2015;110(9):1524–1532.
   PubMed Web of Science ®Google Scholar
• Wrubel J, Stumbo S, Johnson M. Antiretroviral medication support practices among partners of men who have sex with men: a qualitative study. AIDS Patient Care STDS. 2008;22(11):851–858.
   PubMed Web of Science ®Google Scholar
• Qiao S, Li X, Stanton B. Social support and HIV-related risk behaviors: a systematic review of the global literature. AIDS Behav. 2014;18(2):419–441.
   PubMed Web of Science ®Google Scholar
• Jacob N, MacArthur GJ, Hickman M, Campbell R. A qualitative investigation of the role of the family in structuring young people’s alcohol use. Eur J Public Health. 2016;26(1):102–110.
   PubMed Web of Science ®Google Scholar
• Denning P. Harm reduction therapy with families and friends of people with drug problems. J Clin Psychol. 2010;66(2):164–174.
   PubMed Web of Science ®Google Scholar
• Gossop M, Stewart D, Browne N, Marsden J. Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protect effect of coping responses. Addiction. 2002;97(10):1259–1267.
   PubMed Web of Science ®Google Scholar
• Johnson D, Stall R, Smith K. Reliance by gay men and intravenous drug users on friend and family for AIDS-related care. AIDS Care. 1995;7:307–319.
   PubMed Web of Science ®Google Scholar
• Gaston GB, Alleyne-Green B. The impact of African Americans' beliefs about HIV medical care on treatment adherence: a systematic review and recommendations for interventions. AIDS Behav. 2013;17(1):31–40.
   PubMed Web of Science ®Google Scholar
• Neri L, Brancaccio D, Rey LAR, et al. Social support from health care providers is associated with reduced illness intrusiveness in hemodialysis patients. CN. 2011;75(2):125–134.
   Google Scholar
• House J. Work Stress and Social Support. Reading, MA: Addison-Wesley; 1981.
   Google Scholar
• Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4:e349–e356.
   PubMed Web of Science ®Google Scholar
• Palpepu A, Tyndall M, Yip B, O’Shaughnessy MV, Hogg RS, Montaner JS. Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use. J Acquir Immune Defic Syndr. 2003;32:522–526.
   PubMed Web of Science ®Google Scholar
• Edelman EJ, Tetrault JM, Fiellin DA. Substance using in older HIV-infected patients. Curr Opin HIV AIDS. 2014;9(4):317–324.
   PubMed Web of Science ®Google Scholar